-
公开(公告)号:KR100825500B1
公开(公告)日:2008-04-25
申请号:KR1020060108673
申请日:2006-11-06
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N1/20
Abstract: A Lactobacillus reuteri is provided to have a novel plasmid capable of being developed as a shuttle vector of an oral delivery system, thereby being usefully used as an oral delivery system, a probiotics, a digestive, an antibacterial agent and a feed additive. A Lactobacillus reuteri is characterized in that it includes a plasmid pILR091 having a sequence described as SEQ ID : NO. 1, expresses at least one enzyme selected from the group consisting of esterase, esterase lipase, lipase, leucine arylamidase, valine arylamidase, crystine arylamidase, acid phosphatase, naphthol-ASBI-phosphohydrolase, alpha-galactosidase, beta-galactosidase, beta-glucuronidase and alpha-glucosidase and is deposited as a deposition no. KACC91266P.
Abstract translation: 提供了一种罗伊氏乳杆菌以具有能够作为口服递送系统的穿梭载体开发的新型质粒,从而有效地用作口服递送系统,益生菌,消化系统,抗菌剂和饲料添加剂。 一种罗伊氏乳杆菌的特征在于其包含具有SEQ ID NO:1所示序列的质粒pILR091。 1表示选自酯酶,酯酶脂肪酶,脂肪酶,亮氨酸芳基酰胺酶,缬氨酸芳基酰胺酶,结晶芳基酰胺酶,酸性磷酸酶,萘酚-ASBI-磷酸水解酶,α-半乳糖苷酶,β-半乳糖苷酶,β-葡糖苷酸酶和 α-葡萄糖苷酶,并作为沉积物沉积。 KACC91266P。